Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Sayang Awak, Sayang
SUATU tragedi yang menyayat hati terjadi menyebabkan Junaira dan Haziq yatim piatu, lalu tinggal di rumah Datin Ros yang sangat baik. Tetapi Nazif... menyampah sangat dengan mereka berdua. Asyik menjeling sahaja. Suka cari pasal pulak tu! Bagi Junaira, kalau nak lawan api, mestilah dengan air. Sebelum anak Datin Ros itu kenakan dia, dia mesti kenakan Nazif balik. Bila Nazif cuba menyakitkan hati Junaira, hatinya sendiri yang sakit. Junaira suka berloyar buruk. Juga suka buat lawak yang entah apa-apa. Tetapi kadang-kadang dia berasa lucu juga. Namun, amanah Datin Ros yang mahu dia mengahwini Junaira, bagai satu malapetaka baginya. “Aku tak faham kenapa aku disuruh kahwin dengan kau. Sebab aku sayangkan mummy, aku terpaksa terima jugak. Hati aku ni sakit setiap kali pandang muka kau tu, sakit sangat. Semuanya disebabkan kau tu...” Walaupun Junaira tahu kesudahan hubungannya dengan Nazif, cinta untuk lelaki itu kekal tersemat dalam jiwa. Sehinggalah akhirnya, dia tahu kenapa Nazif membenci nya.
Adjective Classes
This book shows that every language has an adjective class and how such classes vary. Thirteen scholars report original research on languages from North, Central and South America, Europe, Africa, Asia and the Pacific. The book throws new light on the nature and classification of adjectives and redefines the cross-linguistic parameters of their variation.
Regents' Proceedings
None
Vectors as Tools for the Study of Normal and Abnormal Growth and Differentiation
Proceedings of the NATO Advanced Research Workshop on Vectors for Transfer and Expression of Genes held in Wilsede, FRG, October 21-24, 1988 on the Occasion of the 40th Anniversary of the Heinrich-Pette-Institut fürExperimentelle Virologie u. Immunologie an der Univ. Hamburg
漢語英譯辭典
None
Combinational Immunotherapy of Cancer: Novel Targets, Mechanisms, and Strategies
Cancer immunotherapy, including immune checkpoint inhibitors (ICIs) and chimeric antigen receptor T-cell (CAR-T) therapy, has revolutionized the paradigm in cancer treatment. However, the clinical outcome of immunotherapy varies considerably among patients and only a minority of patients achieve long-term clinical benefits. This is largely attributed to the fact that existing cancer immunotherapies, which concentrate on several classical targets (CTAL-4, PD-1/PD-L1, etc.) and limited types of immune cell populations (T cells), are insufficient to cope with the complexity of highly heterogeneous tumor microenvironment (TME). This calls for more efforts to not only expand our toolbox for manip...
